Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone.
about
The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.Glycosylation of therapeutic proteins: an effective strategy to optimize efficacyRecombinant follitropin alfa/lutropin alfa in fertility treatment.Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literatureGonadotrophins: The future.A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational studyDose-exposure proportionality of a novel recombinant follicle-stimulating hormone (rFSH), FE 999049, derived from a human cell line, with comparison between Caucasian and Japanese women after subcutaneous administrationTreatment of female infertility with recombinant human luteinising hormone: is there a benefit over other available drugs?Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin.Gonadotropins in doping: pharmacological basis and detection of illicit use.Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley ratsCharacterisation of Population Pharmacokinetics and Endogenous Follicle-Stimulating Hormone (FSH) Levels After Multiple Dosing of a Recombinant Human FSH (FE 999049) in Healthy WomenPopulation Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending DosesAdministration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applications.Early stage development of the glycine-1 re-uptake inhibitor SCH 900435: central nervous system effects compared with placebo in healthy men.Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol.Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris®) in Pituitary-Suppr
P2860
Q24816913-DB603C90-4562-45BA-853E-EC1FF95D878DQ33586660-01069408-1DCB-4F55-8AE7-4EB091A85E6FQ33644799-7B9D7161-57CA-49BA-8E8F-B6C78FFC15D9Q33743109-9C93D5AA-9E45-4358-94B8-940E1FEFFB1CQ34975528-AE504FDF-B945-47C0-B58F-2E35E26F2549Q35197790-A9086CF6-46AB-47C6-AD04-1143F4A5401DQ35203531-CFF41CCB-37D3-4B31-B4AF-A5B77443F112Q35574981-E7590E3B-0858-4994-94DA-D51606824F6DQ36136018-BDC07041-89D8-4CFE-BB00-08A029F363DDQ36736090-FCBBDAC8-3C47-48B7-BD8F-A5DE95CC7A17Q36808666-8C5FD593-14AC-4DC6-9A6E-CFEA0ADCFACEQ36923996-4578B17D-DC24-4658-BB84-433C2FA4869BQ36924006-29099A21-BE72-4556-B4EB-CB21BE44458FQ37207662-7231528B-E66E-4982-96F4-E0B33EB3527FQ37736491-A1A96434-C9C1-4D47-ADA6-411E3CAD7B2DQ43118502-4B3E1384-7993-420A-B958-C22252E6C2BBQ45028601-955872E0-FE2B-4747-98B1-B3767AD0ACD6Q47698952-224EE5A3-025E-4838-ABD2-6B37E6DB6A69
P2860
Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Pharmacokinetic and pharmacody ...... follicle-stimulating hormone.
@en
Pharmacokinetic and pharmacody ...... follicle-stimulating hormone.
@nl
type
label
Pharmacokinetic and pharmacody ...... follicle-stimulating hormone.
@en
Pharmacokinetic and pharmacody ...... follicle-stimulating hormone.
@nl
prefLabel
Pharmacokinetic and pharmacody ...... follicle-stimulating hormone.
@en
Pharmacokinetic and pharmacody ...... follicle-stimulating hormone.
@nl
P2093
P1476
Pharmacokinetic and pharmacody ...... follicle-stimulating hormone.
@en
P2093
Beltrami V
Porchet HC
le Cotonnec JY
P304
P356
10.1016/S0015-0282(97)00503-7
P407
P577
1998-02-01T00:00:00Z